Comerica Bank’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $25.2M | Sell |
264,518
-13,381
| -5% | -$1.31M | 0.1% | 166 |
|
|
2025
Q3 | $27.1M | Sell |
277,899
-4,223
| -1% | -$437K | 0.1% | 185 |
|
|
2025
Q2 | $30.3M | Sell |
282,122
-6,634
| -2% | -$671K | 0.12% | 158 |
|
|
2025
Q1 | $29.1M | Buy |
288,756
+12,067
| +4% | +$1.22M | 0.12% | 155 |
|
|
2024
Q4 | $24.7M | Buy |
276,689
+4,074
| +1% | +$359K | 0.1% | 182 |
|
|
2024
Q3 | $22.8M | Buy |
272,615
+1,439
| +0.5% | +$113K | 0.09% | 207 |
|
|
2024
Q2 | $20.9M | Sell |
271,176
-5,212
| -2% | -$381K | 0.09% | 216 |
|
|
2024
Q1 | $18.9M | Sell |
276,388
-4,793
| -2% | -$308K | 0.08% | 238 |
|
|
2023
Q4 | $16.3M | Buy |
281,181
+9,572
| +4% | +$511K | 0.07% | 256 |
|
|
2023
Q3 | $14.3M | Buy |
+271,609
| New | +$14.2M | 0.07% | 254 |
|
|
2022
Q4 | $8.32M | Buy |
180,801
+373
| +0.2% | +$16.2K | 0.06% | 340 |
|
|
2022
Q3 | $7.39M | Buy |
180,428
+11,066
| +7% | +$444K | 0.06% | 331 |
|
|
2022
Q2 | $6.39M | Buy |
169,362
+1,913
| +1% | +$77.9K | 0.05% | 413 |
|
|
2022
Q1 | $7.89M | Buy |
167,449
+2,367
| +1% | +$103K | 0.06% | 378 |
|
|
2021
Q4 | $7.02M | Sell |
165,082
-8,457
| -5% | -$355K | 0.05% | 409 |
|
|
2021
Q3 | $7.78M | Sell |
173,539
-58,346
| -25% | -$2.58M | 0.05% | 447 |
|
|
2021
Q2 | $10.3M | Sell |
231,885
-7,114
| -3% | -$299K | 0.06% | 337 |
|
|
2021
Q1 | $10.2M | Sell |
238,999
-13,663
| -5% | -$517K | 0.06% | 353 |
|
|
2020
Q4 | $9.36M | Sell |
252,662
-23,011
| -8% | -$829K | 0.06% | 357 |
|
|
2020
Q3 | $10.2M | Buy |
275,673
+624
| +0.2% | +$24K | 0.07% | 263 |
|
|
2020
Q2 | $10.6M | Buy |
275,049
+20,426
| +8% | +$736K | 0.08% | 231 |
|
|
2020
Q1 | $9.4M | Sell |
254,623
-2,425
| -0.9% | -$94.7K | 0.09% | 220 |
|
|
2019
Q4 | $11.2M | Sell |
257,048
-26,715
| -9% | -$1.12M | 0.08% | 225 |
|
|
2019
Q3 | $11.5M | Buy |
283,763
+78
| +0% | +$3.31K | 0.09% | 213 |
|
|
2019
Q2 | $12M | Buy |
283,685
+6,060
| +2% | +$233K | 0.1% | 200 |
|
|
2019
Q1 | $10.7M | Sell |
277,625
-4,626
| -2% | -$177K | 0.09% | 226 |
|
|
2018
Q4 | $10.4M | Buy |
282,251
+4,801
| +2% | +$174K | 0.09% | 229 |
|
|
2018
Q3 | $10M | Sell |
277,450
-82,928
| -23% | -$2.9M | 0.08% | 262 |
|
|
2018
Q2 | $12.2M | Buy |
360,378
+1,256
| +0.3% | +$37.9K | 0.09% | 243 |
|
|
2018
Q1 | $10.4M | Sell |
359,122
-6,197
| -2% | -$168K | 0.07% | 282 |
|
|
2017
Q4 | $10.2M | Buy |
365,319
+6,810
| +2% | +$188K | 0.07% | 308 |
|
|
2017
Q3 | $10.1M | Sell |
358,509
-1,052
| -0.3% | -$29.1K | 0.07% | 282 |
|
|
2017
Q2 | $9.93M | Buy |
359,561
+1,398
| +0.4% | +$37.1K | 0.07% | 274 |
|
|
2017
Q1 | $9.38M | Buy |
358,163
+619
| +0.2% | +$15.1K | 0.07% | 287 |
|
|
2016
Q4 | $8.52M | Buy |
357,544
+9,391
| +3% | +$205K | 0.07% | 297 |
|
|
2016
Q3 | $8.18M | Buy |
348,153
+12,941
| +4% | +$309K | 0.07% | 284 |
|
|
2016
Q2 | $8.1M | Sell |
335,212
-7,778
| -2% | -$168K | 0.07% | 289 |
|
|
2016
Q1 | $6.67M | Buy |
342,990
+9,105
| +3% | +$160K | 0.06% | 332 |
|
|
2015
Q4 | $5.82M | Buy |
333,885
+1,206
| +0.4% | +$21.6K | 0.06% | 356 |
|
|
2015
Q3 | $5.46M | Sell |
332,679
-339,907
| -51% | -$5.81M | 0.05% | 393 |
|
|
2015
Q2 | $11.9M | Buy |
672,586
+329,439
| +96% | +$5.89M | 0.05% | 401 |
|
|
2015
Q1 | $6.09M | Sell |
343,147
-342,621
| -50% | -$5.41M | 0.05% | 392 |
|
|
2014
Q4 | $9.09M | Buy |
685,768
+314,822
| +85% | +$4.02M | 0.04% | 511 |
|
|
2014
Q3 | $4.38M | Sell |
370,946
-46,189
| -11% | -$582K | 0.04% | 531 |
|
|
2014
Q2 | $5.33M | Sell |
417,135
-111,126
| -21% | -$1.44M | 0.05% | 448 |
|
|
2014
Q1 | $7.14M | Buy |
528,261
+17,416
| +3% | +$229K | 0.05% | 349 |
|
|
2013
Q4 | $6.14M | Sell |
510,845
-34,974
| -6% | -$413K | 0.05% | 415 |
|
|
2013
Q3 | $6.41M | Buy |
545,819
+12,618
| +2% | +$136K | 0.04% | 438 |
|
|
2013
Q2 | $4.94M | Buy |
+533,201
| New | +$4.52M | 0.04% | 480 |
|
Other funds holding BSX
Comerica Bank's BSX Position: Q4 2025 in Review
Comerica Bank reduced its Boston Scientific (BSX) stake by 4.8% in Q4 2025, selling an estimated $1.31M and leaving 264,518 shares worth $25.2M. The position accounts for 0.1% of the portfolio, ranked #166.
Comerica Bank first reported a position in BSX in Q2 2013 and has held it in 49 quarters since. The position peaked at $30.3M in Q2 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.
- Comerica Bank held 264,518 shares of Boston Scientific worth $25.2M as of Q4 2025.
- Comerica Bank sold 13,381 Boston Scientific shares in Q4 2025, an estimated $1.31M.
- Boston Scientific made up 0.1% of Comerica Bank's portfolio in Q4 2025, its #166 holding.
- Comerica Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 49 quarters since.
- Comerica Bank's Boston Scientific position peaked at $30.3M in Q2 2025.
- 1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.